Just one day after filing for its IPO, Anthropic announces it’s getting into drug discovery ITSELF.
so basically the AI company that sells tokens to an entire industry may eventually compete with its own customers.
Over the past few months, Anthropic scientists have engaged in deep research partnerships with six organizations developing new medicines. We've also begun drug discovery efforts of our own.
In doing so, we’ve learned much more about how Claude can support the many stages of drug development.
In this blog post, we share some early results from these efforts, and describe how this work fits in with our wider ambitions in the life sciences.